{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:04:54Z","timestamp":1768701894210,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"We thank the research fund from Weifang People's Hospital","award":["(No. 20150018)"],"award-info":[{"award-number":["(No. 20150018)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10787-019-00611-7","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T09:06:04Z","timestamp":1563267964000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood\u2013brain barrier"],"prefix":"10.1007","volume":"27","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohui","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1100\/tsw.2007.187","volume":"7","author":"M B\u00e4ck","year":"2007","unstructured":"B\u00e4ck M (2007) The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Sci World J 7:1422\u20131439","journal-title":"Sci World J"},{"issue":"1","key":"611_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10557-008-6140-9","volume":"23","author":"M B\u00e4ck","year":"2009","unstructured":"B\u00e4ck M (2009) Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc Drugs Ther 23(1):41\u201348","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"611_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/02699050902926317","volume":"23","author":"N Biber","year":"2009","unstructured":"Biber N, Toklu HZ, Solakoglu S, Gultomruk M, Hakan T, Berkman Z, Dulger FG (2009) Cysteinyl-leukotriene receptor antagonist montelukast decreases blood\u2013brain barrier permeability but does not prevent oedema formation in traumatic brain injury. Brain Inj 23(6):577\u2013584","journal-title":"Brain Inj"},{"issue":"12","key":"611_CR4","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.3390\/molecules15129104","volume":"15","author":"S Cam\u00f3s","year":"2010","unstructured":"Cam\u00f3s S, Mallolas J (2010) Experimental models for assaying microvascular endothelial cell pathophysiology in stroke. Molecules 15(12):9104\u20139134","journal-title":"Molecules"},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"2432958","DOI":"10.1155\/2017\/2432958","volume":"2017","author":"F Colazzo","year":"2017","unstructured":"Colazzo F, Gelosa P, Tremoli E, Sironi L, Castiglioni L (2017) Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases. Mediat Inflamm 2017:2432958","journal-title":"Mediat Inflamm"},{"issue":"1","key":"611_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2017.02.125","volume":"486","author":"X Di","year":"2017","unstructured":"Di X, Tang X, Di X (2017) Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: an implication for the treatment of atherosclerosis. Biochem Biophys Res Commun 486(1):58\u201362","journal-title":"Biochem Biophys Res Commun"},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"3454212","DOI":"10.1155\/2017\/3454212","volume":"2017","author":"P Gelosa","year":"2017","unstructured":"Gelosa P, Colazzo F, Tremoli E, Sironi L, Castiglioni L (2017) Cysteinyl leukotrienes as potential pharmacological targets for cerebral diseases. Mediat Inflamm 2017:3454212","journal-title":"Mediat Inflamm"},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0002-9440(10)63937-5","volume":"158","author":"K Gronert","year":"2001","unstructured":"Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN (2001) Selectivity of recombinant human leukotriene D4, leukotriene B4, and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses. Am J Pathol 158:3\u20139","journal-title":"Am J Pathol"},{"key":"611_CR9","first-page":"478","volume":"06","author":"M Hoxha","year":"2017","unstructured":"Hoxha M, Capra V, Malaj V, Sala A, Rovati G (2017) The role of montelukast in cardiovascular events. Atherosclerosis 06:478","journal-title":"Atherosclerosis"},{"issue":"7","key":"611_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796\u2013808","journal-title":"Nat Med"},{"issue":"3","key":"611_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","volume":"129","author":"E Ingelsson","year":"2012","unstructured":"Ingelsson E, Yin L, B\u00e4ck M (2012) Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol 129(3):702\u2013707","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"611_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","volume":"69","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69(14):1404\u20131410","journal-title":"Neurology"},{"key":"611_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jaci.2004.07.039","volume":"114","author":"KS Lee","year":"2004","unstructured":"Lee KS, Kim SR, Park HS, Jin GY, Lee YC (2004) Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol 114:1093\u20131099","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"611_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84\u201391","journal-title":"Stroke"},{"issue":"23","key":"611_CR15","doi-asserted-by":"publisher","first-page":"20820","DOI":"10.1074\/jbc.M203163200","volume":"277","author":"A Maekawa","year":"2002","unstructured":"Maekawa A, Austen KF, Kanaoka Y (2002) Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 277(23):20820\u201320824","journal-title":"J Biol Chem"},{"issue":"10","key":"611_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","volume":"36","author":"P Mergenthaler","year":"2013","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, Meisel A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci 36(10):587\u2013597","journal-title":"Trends Neurosci"},{"issue":"6","key":"611_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","volume":"36","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden M, Gleasonw MM, Togias A (2006) Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 36(6):689\u2013703","journal-title":"Clin Exp Allergy"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.160.4.1043","volume":"160","author":"LG Pologe","year":"1984","unstructured":"Pologe LG, Cramer EB, Pawlowski NA, Abraham E, Cohn ZA, Scott WA (1984) Stimulation of human endothelial cell prostacyclin synthesis by select leukotrienes. J Exp Med 160:1043\u20131053","journal-title":"J Exp Med"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"490968","DOI":"10.1100\/2012\/490968","volume":"2012","author":"G Riccioni","year":"2012","unstructured":"Riccioni G, B\u00e4ck M (2012) Leukotrienes as modifiers of preclinical atherosclerosis? Sci World J 2012:490968","journal-title":"Sci World J"},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2015.03.018","volume":"1623","author":"PT Ronaldson","year":"2015","unstructured":"Ronaldson PT, Davis TP (2015) Targeting transporters: promoting blood\u2013brain barrier repair in response to oxidative stress injury. Brain Res 1623:39\u201352","journal-title":"Brain Res"},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"H796","DOI":"10.1152\/ajpheart.00712.2012","volume":"304","author":"H Shi","year":"2013","unstructured":"Shi H, Sheng B, Zhang F, Wu C, Zhang R, Zhu J, Xu K, Kuang Y, Jameson SC, Lin Z, Wang Y, Chen J, Jain MK, Atkins GB (2013) Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am J Physiol Heart Circ Physiol 304:H796\u2013H805","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"611_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1365-2222.2001.01051.x","volume":"31","author":"JC Virchow","year":"2001","unstructured":"Virchow JC, Faehndrich S, Nassenstein C, Bock S, Matthys H, Luttmann W (2001) Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin Exp Allergy 31(6):836\u2013844","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"611_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000081072","volume":"73","author":"GL Yu","year":"2005","unstructured":"Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH (2005) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73(1):31\u201340","journal-title":"Pharmacology"},{"key":"611_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/bj3610267","volume":"361","author":"YY Zhang","year":"2002","unstructured":"Zhang YY, Walker JL, Huang A, Keaney JF, Clish CB, Serhan CN, Loscalzo J (2002) Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem J 361:267\u2013276","journal-title":"Biochem J"},{"issue":"3","key":"611_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neulet.2004.03.088","volume":"363","author":"W Zhang","year":"2004","unstructured":"Zhang W, Hu H, Zhang L, Chen Z, Wei E (2004) Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 363(3):247\u2013251","journal-title":"Neurosci Lett"},{"issue":"4","key":"611_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.2042-7158.2010.01238.x","volume":"63","author":"R Zhao","year":"2011","unstructured":"Zhao R, Shi WZ, Zhang YM, Fang SH, Wei EQ (2011) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. J Pharm Pharmacol 63(4):550\u2013557","journal-title":"J Pharm Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-019-00611-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T23:32:57Z","timestamp":1594769577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-019-00611-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s10787-019-00611-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}